Macrogenics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.04

+0.03 (+0.75%)

As of Aug 15, 2:16 AM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 62%

Hold 5 38%

Sell 0 0%

Price Target

Analyst Price Target +985.4% upside

Low Target $27.62

Average Target $43.85

High Target $64.74

Current Price $4.04

Current
$4.04

Target
$43.85

$27.62 $43.85 avg $64.74

Scenario Analysis

Bear Case

$27.62

583.7%

Low target

Base Case

$43.85

+985.4%

Avg target

Bull Case

$64.74

+1,502.5%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$5.08

-20.5% from high

52-Week Low

$1.29

+213.2% from low

Target vs 52W High

$43.85

+763.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%